RTGN RetinalGenix Technologies Inc. OTC · United States

RetinalGenix Technologies (RTGN) news

RetinalGenix Technologies Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker RTGN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest RetinalGenix Technologies news

We have not published a story on RetinalGenix Technologies yet. When there is news, it will appear here.

RetinalGenix Technologies annual financials

Line	FY2025	FY2024
Research and development	$83,040	$373,271
Net income (loss)	-$2.4 million	-$4.3 million
Cash from operations	-$558,350	-$741,936

Latest balance sheet, Sep 30, 2023 (10-Q): cash and equivalents $44.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about RetinalGenix Technologies

What is the ticker symbol of RetinalGenix Technologies?

RetinalGenix Technologies Inc. trades under the ticker RTGN on OTC.

Where is RetinalGenix Technologies listed?

RetinalGenix Technologies Inc. is listed on OTC.

Which country or territory is RetinalGenix Technologies listed under?

Our directory records RetinalGenix Technologies Inc. under United States.

Does aibio.space cover RetinalGenix Technologies?

aibio.space lists RetinalGenix Technologies Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Is RetinalGenix Technologies profitable?

RetinalGenix Technologies Inc. reported a net loss of $2.4 million for the fiscal year ended Dec 31, 2025, and used $558,350 of cash in operations, per its annual report to the SEC.

How much does RetinalGenix Technologies spend on research and development?

$83,040 in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does RetinalGenix Technologies have?

$44 in cash at Sep 30, 2023, per its 10-Q.

Investor discussion: RetinalGenix Technologies

Members talk about RetinalGenix Technologies (RTGN). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at RetinalGenix Technologies, newest first. Each line links the filing it comes from.

Jul 15, 2026Legal
Reported a change of independent auditor. SEC Form 8-K (Items 4.01,9.01). Source
May 15, 2026Distress
Told the SEC a periodic report would be filed late. SEC Form NT 10-Q. Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:RTGN on TradingView.

Listing details

Company: RetinalGenix Technologies Inc.
Ticker: RTGN
Listing: OTC
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction